Task shifting redefined: removing social and structural barriers to improve delivery of HIV services for people who inject drugs

Harm Reduction Journal

Thomas Kerr²  Lianping Ti¹ 

[1] British Columbia Centre for Excellence in HIV/AIDS, St. Paul’s Hospital, 608-1081 Burrard Street, Vancouver, BC V6Z 1Y6, Canada;Department of Medicine, St. Paul’s Hospital, University of British Columbia, 608-1081 Burrard Street, Vancouver, BC V6Z 1Y6, Canada

关键词: HIV services;    Stigma and discrimination;    People who inject drugs;    Task shifting;   

Others  :  809850
DOI  :  10.1186/1477-7517-10-20

 received in 2012-08-23, accepted in 2013-09-24,  发布年份 2013

【 摘 要 】

HIV infection among people who inject drugs (IDU) remains a major global public health challenge. However, among IDU, access to essential HIV-related services remains unacceptably low, especially in settings where stigma, discrimination, and criminalization exist. These ongoing problems account for a significant amount of preventable morbidity and mortality within this population, and indicate the need for novel approaches to HIV program delivery for IDU. Task shifting is a concept that has been applied successfully in African settings as a way to address health worker shortages. However, to date, this concept has not been applied as a means of addressing the social and structural barriers to HIV prevention and treatment experienced by IDU. Given the growing evidence demonstrating the effectiveness of IDU-run programs in increasing access to healthcare, the time has come to extend the notion of task shifting and apply it in settings where stigma, discrimination, and criminalization continue to pose significant barriers to HIV program access for IDU. By involving IDU more directly in the delivery of HIV programs, task shifting may serve to foster a new era in the response to HIV/AIDS among IDU.

【 授权许可】

   
2013 Ti and Kerr; licensee BioMed Central Ltd.

【 参考文献 】

• [1]WHO, UNODC, UNAIDS: WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users. Geneva: WHO; 2009.
• [2]Reference Group to the UN on HIV and injecting drug use: Consensus Statement of the Reference Group to the United Nations on HIV and Injecting Drug Use 2010. New South Wales: Reference Group to the UN on HIV and injecting drug use; 2010.
• [3]Mathers B, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick R, Myers B, Ambekar A, Strathdee S: HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet 2010, 375:1014-1028.
• [4]Csete J, Kaplan K, Hayashi K, Fairbairn N, Suwannawong P, Zhang R, Wood E, Kerr T: Compulsory drug detention center experiences among a community-based sample of injection drug users in Bangkok, Thailand. BMC Int Health Hum Rights 2011, 11:11. BioMed Central Full Text
• [5]Wolfe D: Paradoxes in antiretroviral treatment for injecting drug users: Access, adherence and structural barriers in Asia and the former Soviet Union. Int J Drug Policy 2007, 18:246-254.
• [6]Small W, Wood E, Betteridge G, Montaner J, Kerr T: The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: a qualitative study. AIDS Care 2009, 21:708-714.
• [7]Beyrer C, Malinowska-Sempruch K, Kamarulzaman A, Kazatchkine M, Sidibe M, Strathdee S: Time to act: A call for comprehensive responses to HIV in people who use drugs. Lancet 2010, 376:551-563.
• [8]Human Rights Watch, Thai AIDS Treatment Action Group: Deadly denial. Thailand: Barriers to HIV/AIDS treatment for people who use drugs in Thailand; 2007.
• [9]Chan K, Stoove M, Sringernyuang L, Reidpath D: Stigmatization of AIDS patients: Disentangling Thai nursing students’ attitudes towards HIV/AIDS, drug use, and commercial sex. AIDS Behav 2008, 12:146-157.
• [10]Paxton S, Gonzales G, Uppakaew K, Abraham K, Okta S, Green C, Nair K, Parwati Merati T, Thephthien B, Marin M, Quesada A: AIDS-related discrimination in Asia. AIDS Care 2005, 17:413-424.
• [11]Ding L, Landon B, Wilson I, Wong M, Shapiro M, Cleary P: Predictors and Consequences of Negative Physician Attitudes Toward HIV-Infected Injection Drug Users. Arch Intern Med 2005, 165:618-623.
• [12]Escaffre N, Morin M, Bouhnik A, Fuzibet J, Gastaut J, Obadia Y, Moatti J: Injecting drug users’ adherence to HIV antiretroviral treatments: Physicians’ beliefs. AIDS Care 2000, 12:723-730.
• [13]Wood E, Kerr T, Tyndall M, Montaner J: A review of barriers and facilitators of HIV treatment among injection drug users. AIDS 2008, 22:1247-1256.
• [14]Ford K, Wirawan D, Sumantera G, Sawitri A, Stahre M: Voluntary HIV testing, disclosure, and stigma among injection drug users in Bali, Indonesia. AIDS Educ Prev 2004, 16:487-498.
• [15]Rudolph A, Davis W, Quan V, Ha T, Minh N, Gregowski A, Salter M, Celentano D, Go V: Perceptions of community- and family-level injection drug user (IDU)- and HIV-related stigma, disclosure decisions and experiences with layered stigma among HIV-positive IDUs in Vietnam. AIDS Care 2012, 24:239-244.
• [16]Johnson M, Chesney M, Neilands T, Dilworth S, Remien R, Weinhardt L, Wong L, Morin S, NIMH Health Living Project Team: Disparities in Reported Reasons for Not Initiating or Stopping Antiretroviral Treatment Among a Diverse Sample of Persons Living with HIV. J Gen Int Med 2008, 24:247-251.
• [17]Callaghan M, Ford N, Schneider H: A systematic review of task-shifting for HIV treatment and care in Africa. Hum Resour Health 2010., 8
• [18]Brugha R, Kadzandira J, Simbaya J, Dicker P, Mwapasa V, Walsh A: Health workforce responses to global health initiatives funding: a comparison of Malawi and Zambia. Hum Resour Health 2010., 8
• [19]Curran K, Njeuhmeli E, Mirelman A, Dickson K, Adamu T, Cherutich P, Mahler H, Fimbo B, Mavuso T, Albertini J, Fitzgerald L, Bock N, Reed J, Castor D, Stanton D: Voluntary Medical Male Circumcision: Strategies for Meeting the Human Resource Needs of Scale-Up in Southern and Eastern Africa. PLoS Med 2011, 8:e1001129.
• [20]Shumbusho F, Van Griensven J, Lowrance D, Turate I, Weaver M, Price J, Binagwaho A: Task Shifting for Scale-up of HIV Care: Evaluation of Nurse-Centered Antiretroviral Treatment at Rural Health Centers in Rwanda. PLoS Med 2009, 6:e1000163.
• [21]Jaffar S, Amuron B, Foster S, Birungi J, Levin J, Namara G, Nabiryo C, Ndembi N, Kyomuhangi R, Opio A, Bunnell R, Tappero J, Mermin J, Coutinho A, Grosskurth H, Jinja Trial Team: Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: A cluster-randomised equivalence trial. Lancet 2009, 374:2080-2089.
• [22]Sanjana P, Torpey K, Schwarzwalder A, Simumba C, Kasonde P, Nyirenda L, Kapanda R, Kakungu-Simpungwe M, Kabaso M, Thompson C: Task-shifting HIV counselling and testing services in Zambia: The role of lay counsellors. Hum Resour Health 2009., 7
• [23]Bemelmans M, Van Den Akker T, Ford N, Philips M, Zachariah R, Harries A, Schouten E, Hermann K, Mwagomba B, Massaguoi M: Providing universal access to antiretroviral therapy in Thyolo, Malawi through task shifting and decentralization of HIV/AIDS care. Trop Med Int Health 2010, 15:1413-1420.
• [24]Selke H, Kimaiyo S, Sidle J, Vedanthan R, Tierney W, Shen C, Denski C, Katschke A, Wools-Kaloustian K: Task-shifting of antiretroviral delivery from health care workers to persons living with HIV/AIDS: clinical outcomes of a community-based program in Kenya. J Acquir Immune Defic Syndr 2010, 55:483-490.
• [25]Pedrana A, Guy R, Bowring A, Hellard M, Stoove M: Community models of HIV testing for men who have sex with men (MSM): Systematic Review 2011. Burnet Institute: Melbourne; 2011.
• [26]Boseley S: Crisis looms as Global Fund forced to cut back on Aids, malaria and TB grants. The Guardian 2011.
• [27]York G: Economic crisis hits health aid that has helped millions as donors cut back. The Globe and Mail 2011.
• [28]Kerr T, Hayashi K, Fairbairn N, Kaplan K, Suwannawong P, Zhang R, Wood E: Expanding the reach of harm reduction in Thailand: Experiences with a drug user-run drop-in centre. Int J Drug Policy 2010, 21:255-258.
• [29]Hayashi K, Wood E, Wiebe L, Qi J, Kerr T: An external evaluation of a peer-run outreach-based syringe exchange in Vancouver, Canada. Int J Drug Policy 2010, 21:418-421.
• [30]Smyrnov P, Broadhead R, Datsenko O, Matiyash O: Rejuvenating harm reduction projects for injection drug users: Ukraine’s nationwide introduction of peer-driven interventions. Int J Drug Policy 2012, 23:141-147.
• [31]WHO, UNODC: Guidance on Testing and Counselling for HIV in Settings Attended by People Who Inject Drugs: Improving Access to Treatment, Care and Prevention. Geneva: WHO; 2009.
• [32]Broadhead RS, Heckathorn DD, Altice FL, Van Hulst Y, Carbone M, Friedland GH, O’Connor PG, Selwyn PA: Increasing drug users’ adherence to HIV treatment: results of a peer-driven intervention feasibility study. Soc Sci Med 2002, 55:235-246.
• [33]Irwin K, Karchevsky E, Heimer R, Badrieva L: Secondary syringe exchange as a model for HIV prevention programs in the Russian Federation. Subst Use Misuse 2006, 41:979-999.
• [34]Snead J, Downing M, Lorvick J, Garcia B, Thawley R, Kegeles S, Edlin BR: Secondary syringe exchange among injection drug users. J Urban Health 2003, 80:330-348.